Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-011595

SVP & Chief Operating Officer sold 4,879 shares at $82.94 ($404,664)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nicholson John SVP & Chief Operating Officer 2018-02-16 Sale −4,879 $82.94 $404,664 387,657 D: show line 1 in the form
Open-market sales · 4,879 sh · avg $82.94 · $404,664
Loading xslF345X03/doc4.xml…